Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported a standalone net profit of Rs. 82.44 crore for the FY25 ended March 2025 as against net profit of Rs. 93.37 crore FY24.
Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets USP...
Zydus Lifesciences is developing a new semaglutide formulation for diabetes and obesity, two rapidly growing chronic conditions that are becoming increasingly debilitating. Rather than requiring patients to...
According to Anish Bafna, CEO and Managing Director of Healthium Medtech, sustainability is growing a vital factor in global healthcare finding, especially across the US and Europe.
-min.png)
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has advised its members to freshly apply again to the Production Linked Incentive.
Indian Pharma Expands as Global Players Cut Insulin FocusIndian pharmaceutical firms like Eris Lifesciences, Lupin, Mankind, and Wockhardt are quickly growing their footprint in India's insulin market, long monopolized by the likes of Novo...
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, today announced its earnings for the fourth quarter and full year FY25.
DoP Invites Fresh Applications Under PLI Scheme for Bulk DrugsThe Department of Pharmaceuticals (DoP) has sought new applications under the Production Linked Incentive (PLI) scheme for bulk drugs, for products that have not been applied for or...
The pharmaceutical industry encounters pressing difficulties pertaining to products getting expired quickly while production and quality control costs remain elevated. Furthermore, transporting medications requires advanced logistics systems for refr
The Embassy of India in Santiago, Chile sent a formal communication request to the Pharmaceuticals Export Promotion Council of India.
.jpg)
.jpg)
, CDSCO.jpg)